Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2024 group results

Feb 14 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2024    Dec 31, 2023   Dec 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           10.04           9.34           10.70         5.50    
               (+7.5 pct)      (-2.2 pct)     (+6.6 pct)    (+7.2 pct) 
  Operating      318 mln         519 mln        490 mln      290 mln   
               (-38.7 pct)     (-36.3 pct)    (+53.8 pct)  (-10.2 pct) 
  Recurring      364 mln         653 mln        580 mln      360 mln   
               (-44.2 pct)     (-17.4 pct)    (+59.2 pct)   (+6.7 pct) 
  Net
  Net            262 mln         442 mln        430 mln      280 mln   
               (-40.8 pct)     (-14.4 pct)    (+64.1 pct)   (+8.4 pct) 
  EPS           45.05 yen       75.97 yen      75.04 yen    48.86 yen  
  Ann Div       50.00 yen       30.00 yen      50.00 yen               
  -Q2 Div       14.00 yen       14.00 yen      25.00 yen               
  -Q4 Div       36.00 yen       16.00 yen      25.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news